Glucose-Lowering Effects of an Oral Glucokinase (GK) Activator, MK-0941, in Patients with Type 2 Diabetes (T2DM) Inadequately Controlled by Metformin

被引：0
|
作者：
O'Neill, Edward A.
Migoya, Elizabeth
Miller, Jutta
Moreau, Meghan
Maganti, Lata
Larson, Patrick
Gutierrez, Maria
Denoia, Emanuel
Wagner, John A.
Stoch, Aubrey
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2287-PO
引用
收藏
页码：A608 / A608
页数：1
相关论文
共 50 条
  • [21] BAYESIAN NETWORK META-ANALYSIS TO ASSESS RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED WITH METFORMIN
    Pacou, M.
    Taieb, V
    Abrams, K. R.
    Diels, J.
    van Sanden, S.
    Garg, M.
    Schroeder, M.
    Kaur, V
    Nielsen, A. T. N.
    Nuhoho, S.
    Neslusan, C.
    Hemels, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A609 - A609
  • [22] Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids
    Sansome, Daniel J.
    Xie, Cong
    Veedfald, Simon
    Horowitz, Michael
    Rayner, Christopher K.
    Wu, Tongzhi
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (02): : 141 - 148
  • [23] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes
    Tomlinson, Brian
    Hu, Miao
    Zhang, Yuzhen
    Chan, Paul
    Liu, Zhong-Min
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (11) : 1267 - 1271
  • [24] Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin
    Bosi, Emanuele
    Camisasca, Riccardo Paolo
    Collober, Carole
    Rochotte, Erika
    Garber, Alan J.
    [J]. DIABETES CARE, 2007, 30 (04) : 890 - 895
  • [25] Effects on lipid metabolism of metformin and troglitazone, alone and in combination, in patients with type 2 diabetes mellitus (T2DM)
    Lee, I
    Maggs, DG
    Katz, D
    Spollett, GR
    Page, SL
    Rife, FS
    Inzucchi, SE
    [J]. DIABETES, 2002, 51 : A105 - A105
  • [26] Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations
    Lawrence Blonde
    Susana Dipp
    Daniel Cadena
    [J]. Advances in Therapy, 2018, 35 : 939 - 965
  • [27] Improved blood pressure (BP) lowering in hypertensive patients (pts) with type 2 diabetes (T2DM) with vildagliptin combined with metformin compared with metformin alone
    Bosi, E.
    Shao, Q.
    Cohen, S. E.
    [J]. DIABETES, 2007, 56 : A549 - A549
  • [28] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
    Pavlicek, V.
    [J]. DIABETOLOGE, 2011, 7 (01): : 37 - 38
  • [29] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    [J]. DIABETES, 2014, 63 : A277 - A277
  • [30] The Usage of Metformin Despite of Existing Contraindications in Type 2 Diabetes Mellitus (T2DM) Patients
    Kosmalski, Marcin
    Drozdowska, Agata
    Drzewoski, Jozef
    [J]. DIABETES, 2011, 60 : A311 - A312
12345